Vigil Neuroscience, Inc.
VIGL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $69 | $131 | $396 | $347 |
| - Cash | $39 | $52 | $187 | $91 |
| + Debt | $13 | $14 | $0 | $1 |
| Enterprise Value | $43 | $93 | $210 | $257 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$84 | -$88 | -$68 | -$42 |
| % Margin | – | – | – | – |
| Net Income | -$84 | -$83 | -$68 | -$43 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.07 | -2.13 | -2.16 | -1.57 |
| % Growth | 2.8% | 1.4% | -37.6% | – |
| Operating Cash Flow | -$51 | -$70 | -$65 | -$39 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$51 | -$71 | -$66 | -$40 |